WBA Quote, Financials, Valuation and Earnings

CVS Health has a net margin of -8% compared to Walgreens Boots Alliance's net margin of 0.09%. Walgreens Boots Alliance's return on equity of -43.52% beat CVS Health's return on equity of 6.68%.

Walgreens Boots Alliance has a consensus price target of $10.36, signalling upside risk potential of 9.02%. On the other hand CVS Health has an analysts' consensus of $66.26 which suggests that it could grow by 44.76%. Given that CVS Health has higher upside potential than Walgreens Boots Alliance, analysts believe CVS Health is more attractive than Walgreens Boots Alliance.

Walgreens Boots Alliance has a beta of 0.646, which suggesting that the stock is 35.445% less volatile than S&P 500. In comparison CVS Health has a beta of 0.595, suggesting its less volatile than the S&P 500 by 40.471%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 10.53%. CVS Health offers a yield of 5.81% to investors and pays a quarterly dividend of $0.67 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. CVS Health pays out 37.54% of its earnings as a dividend. CVS Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Walgreens Boots Alliance quarterly revenues are $37.5B, which are smaller than CVS Health quarterly revenues of $95.4B. Walgreens Boots Alliance's net income of -$3B is lower than CVS Health's net income of $87M. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while CVS Health's PE ratio is 11.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.06x versus 0.16x for CVS Health. Usually stocks with elevated PS ratios are considered overvalued.

Johnson & Johnson has a net margin of -8% compared to Walgreens Boots Alliance's net margin of 11.99%. Walgreens Boots Alliance's return on equity of -43.52% beat Johnson & Johnson's return on equity of 20.88%.

Walgreens Boots Alliance has a consensus price target of $10.36, signalling upside risk potential of 9.02%. On the other hand Johnson & Johnson has an analysts' consensus of $172.43 which suggests that it could grow by 19.59%. Given that Johnson & Johnson has higher upside potential than Walgreens Boots Alliance, analysts believe Johnson & Johnson is more attractive than Walgreens Boots Alliance.

Walgreens Boots Alliance has a beta of 0.646, which suggesting that the stock is 35.445% less volatile than S&P 500. In comparison Johnson & Johnson has a beta of 0.514, suggesting its less volatile than the S&P 500 by 48.607%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 10.53%. Johnson & Johnson offers a yield of 3.41% to investors and pays a quarterly dividend of $1.24 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. Johnson & Johnson pays out 33.48% of its earnings as a dividend. Johnson & Johnson's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Walgreens Boots Alliance quarterly revenues are $37.5B, which are larger than Johnson & Johnson quarterly revenues of $22.5B. Walgreens Boots Alliance's net income of -$3B is lower than Johnson & Johnson's net income of $2.7B. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while Johnson & Johnson's PE ratio is 23.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.06x versus 3.99x for Johnson & Johnson. Usually stocks with elevated PS ratios are considered overvalued.

SunLink Health Systems has a net margin of -8% compared to Walgreens Boots Alliance's net margin of -6.93%. Walgreens Boots Alliance's return on equity of -43.52% beat SunLink Health Systems's return on equity of -5.08%.

Walgreens Boots Alliance has a consensus price target of $10.36, signalling upside risk potential of 9.02%. On the other hand SunLink Health Systems has an analysts' consensus of -- which suggests that it could fall by --. Given that Walgreens Boots Alliance has higher upside potential than SunLink Health Systems, analysts believe Walgreens Boots Alliance is more attractive than SunLink Health Systems.

Walgreens Boots Alliance has a beta of 0.646, which suggesting that the stock is 35.445% less volatile than S&P 500. In comparison SunLink Health Systems has a beta of 1.398, suggesting its more volatile than the S&P 500 by 39.847%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 10.53%. SunLink Health Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. SunLink Health Systems pays out -- of its earnings as a dividend.

Walgreens Boots Alliance quarterly revenues are $37.5B, which are larger than SunLink Health Systems quarterly revenues of $7.9M. Walgreens Boots Alliance's net income of -$3B is lower than SunLink Health Systems's net income of -$549K. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while SunLink Health Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.06x versus 0.20x for SunLink Health Systems. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of -8% compared to Walgreens Boots Alliance's net margin of 6.11%. Walgreens Boots Alliance's return on equity of -43.52% beat UnitedHealth Group's return on equity of 14.51%.

Walgreens Boots Alliance has a consensus price target of $10.36, signalling upside risk potential of 9.02%. On the other hand UnitedHealth Group has an analysts' consensus of $635.85 which suggests that it could grow by 23.95%. Given that UnitedHealth Group has higher upside potential than Walgreens Boots Alliance, analysts believe UnitedHealth Group is more attractive than Walgreens Boots Alliance.

Walgreens Boots Alliance has a beta of 0.646, which suggesting that the stock is 35.445% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.617, suggesting its less volatile than the S&P 500 by 38.345%.

Walgreens Boots Alliance has a quarterly dividend of $0.25 per share corresponding to a yield of 10.53%. UnitedHealth Group offers a yield of 1.6% to investors and pays a quarterly dividend of $2.10 per share. Walgreens Boots Alliance pays -14.59% of its earnings as a dividend. UnitedHealth Group pays out 30.21% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Walgreens Boots Alliance quarterly revenues are $37.5B, which are smaller than UnitedHealth Group quarterly revenues of $99.2B. Walgreens Boots Alliance's net income of -$3B is lower than UnitedHealth Group's net income of $6.1B. Notably, Walgreens Boots Alliance's price-to-earnings ratio is -- while UnitedHealth Group's PE ratio is 33.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Walgreens Boots Alliance is 0.06x versus 1.22x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.